| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 49 companies in the Life Sciences Tools & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 1,837 | $180.79 | $332,111.23 | - | +5.2% | -14.0% | |
| Jun 23, 2021 | VCYT Veracyte, Inc. | Kennedy Giulia C78 | Chief Scientific &Med Officer | Sell | 4,375 | $39.75 | $173,913.69 | -7.8% | +25.8% | -44.2% | |
| Jun 23, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 1,837 | $180.79 | $332,111.23 | - | +5.2% | -14.0% | |
| Jun 23, 2021 | TWST Twist Bioscience Corp | Chess Robert84 | Director | Sell | 4,000 | $120.10 | $480,408.80 | -5.6% | -0.1% | -68.3% | |
| Jun 23, 2021 | NTRA Natera, Inc. | Rabinowitz Daniel48 | Sec. And Chief Legal Officer | Sell | 449 | $115.18 | $51,714.52 | -0.9% | +7.6% | -66.2% | |
| Jun 23, 2021 | CSTL Castle Biosciences Inc | Maetzold Derek J69 | Pres. &Chief Exec. Officer | Sell | 20,000 | $74.81 | $1,496,237.22 | -1.0% | -1.0% | -70.4% | |
| Jun 23, 2021 | NTRA Natera, Inc. | Chapman Steven Leonard56 | CEO And President | Sell | 1,662 | $115.18 | $191,424.34 | -2.3% | +7.6% | -66.2% | |
| Jun 23, 2021 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 205 | $115.18 | $23,611.31 | - | +7.6% | -66.2% | |
| Jun 23, 2021 | NTRA Natera, Inc. | Rabinowitz Matthew59 | Executive Chairman | Sell | 99 | $115.18 | $11,402.53 | - | +7.6% | -66.2% | |
| Jun 23, 2021 | NTRA Natera, Inc. | Brophy Michael Burkes47 | Chief Financial Officer | Sell | 430 | $115.18 | $49,526.15 | -0.4% | +7.6% | -66.2% | |
| Jun 22, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 21,478 | $182.11 | $3,911,448.93 | -0.2% | -0.1% | -22.7% | |
| Jun 22, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 21,478 | $182.11 | $3,911,448.93 | -0.2% | -0.1% | -22.7% | |
| Jun 21, 2021 | TWST Twist Bioscience Corp | Banyai William81 | See Remarks | Sell | 20,000 | $114.68 | $2,293,622.65 | -0.6% | -2.3% | -72.2% | |
| Jun 18, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 10,188 | $181.10 | $1,845,094.63 | - | +4.1% | -23.8% | |
| Jun 18, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 10,188 | $181.10 | $1,845,094.63 | - | +4.1% | -23.8% | |
| Jun 17, 2021 | PSNL Personalis, Inc. | Chen Richard70 | Chief Scientific Officer | Sell | 1,101 | $22.75 | $25,047.75 | -1.4% | -12.7% | -86.7% | |
| Jun 17, 2021 | CSTL Castle Biosciences Inc | Juvenal Tobin W71 | Chief Commercial Officer | Sell | 10,000 | $75.40 | $754,000.00 | -78.0% | -1.8% | -79.0% | |
| Jun 17, 2021 | CSTL Castle Biosciences Inc | Kabakoff David S74 | Director | Sell | 30,000 | $75.07 | $2,252,088.00 | -5.6% | -1.8% | -79.0% | |
| Jun 17, 2021 | PSNL Personalis, Inc. | Tachibana Aaron68 | Chief Financial Officer | Sell | 2,421 | $22.75 | $55,077.75 | -1.3% | -12.7% | -86.7% | |
| Jun 17, 2021 | MYGN Myriad Genetics Inc | Spiegelman Daniel K59 | Director | Sell | 3,139 | $30.52 | $95,794.75 | -11.9% | +6.7% | -46.0% | |
| Jun 17, 2021 | A Agilent Technologies, Inc. | Grau Dominique70 | Senior Vice President | Sell | 1,968 | $145.10 | $285,562.70 | -2.4% | +18.4% | -22.9% | |
| Jun 17, 2021 | NTRA Natera, Inc. | Sheena Jonathan46 | Director, Co-founder | Sell | 19,000 | $101.77 | $1,933,572.71 | -0.8% | +16.4% | -67.5% | |
| Jun 17, 2021 | CSTL Castle Biosciences Inc | Stokes Frank70 | Chief Financial Officer | Sell | 15,000 | $73.03 | $1,095,380.89 | -45.8% | -1.8% | -79.0% | |
| Jun 16, 2021 | MEDP Medpace Holdings, Inc. | Troendle August J.71 | President &CEO | Sell | 33,119 | $181.54 | $6,012,508.69 | -0.3% | +1.2% | -26.1% | |
| Jun 16, 2021 | MEDP Medpace Holdings, Inc. | Medpace Investors, LLC69 | 10% Owner | Sell | 33,119 | $181.54 | $6,012,508.69 | -0.3% | +1.2% | -26.1% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.